IDiyas

For the Inventor, By the Inventor

Los Angeles, CA, United States of America

Neurosigma, Inc.


USPTO Granted Patents = 10



Trademarks = 5

Forward Citations = 185

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Ian A Cook (6 out of 24 patents)

silverMedal Leon Ekchian (6 out of 10 patents)

bronzeMedal Christopher M DeGiorgio (5 out of 16 patents)

4.  Colin Kealey (4 out of 18 patents)

5.  Patrick R Miller (4 out of 14 patents)

6.  Alejandro Covalin (1 out of 23 patents)

7.  Antonio A F Desalles (1 out of 1 patent)

8.  Alessandra Gorgulho (1 out of 1 patent)

9.  Antonio Afonso Ferreira De Salles (1 out of 1 patent)

10.  Antonio Desalles (0 patent)

11.  Patrick Miller (0 patent)

12.  Christopher M Degiorgio (0 patent)

13.  Antonio Desalles (0 patent)

14.  Patrick Miller (0 patent)

15.  Christopher M Degiorgio (0 patent)


10 patents:

1. 10537729 - Trigeminal neurostimulation based upon pulse counting and chronobiology (2020-01-21),
2. 10525254 - Cutaneous electrode (2020-01-07),
3. 10195435 - Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders (2019-02-05),
4. 10035013 - Subcutaneous electrodes for cranial nerve stimulation (2018-07-31),
5. 10016601 - Pulse generator for cranial nerve stimulation (2018-07-10),
6. 9731127 - Modulation of autonomic nervous system activity and integrated electrode assemblies for trigeminal neurostimulation (2017-08-15),
7. 9675794 - Cutaneous electrode (2017-06-13),
8. 9511223 - Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders (2016-12-06),
9. 8958880 - Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders (2015-02-17),
10. 8257684 - Methods for identifying and targeting autonomic brain regions (2012-09-04),
Neurosigma, Inc. is a medical technology company focused on developing non-invasive neuromodulation therapies for neurological and neuropsychiatric disorders. Their flagship product, the Monarch eTNS System, is FDA cleared for the treatment of ADHD and is also being studied for other conditions such as epilepsy and depression.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

10 Patents

#187 in Los Angeles, CA

#6,875 in California

#28,925 in US

#54,204 in the World

...
Los Angeles, CA, United States of America

Neurosigma, Inc.

Forward Citations = 185

27 inventors:

goldMedal Ian A Cook (6 out of 24 patents)

silverMedal Leon Ekchian (6 out of 10 patents)

bronzeMedal Christopher M DeGiorgio (5 out of 16 patents)

4.  Colin Kealey (4 out of 18 patents)

5.  Patrick R Miller (4 out of 14 patents)

Please report any incorrect information to support@idiyas.com
Loading…